Atrys Health, S.A.

€2.65As of Sun 8 Nov 2026, 12:00 UTC
BME:ATRYHealthcare
Country Spain
PE (Fwd) •••
TSR 10Y CAGR 7.39%
Div yield —
ROE (24.57%)
Biotechnology
Beta (5Y) 0.53
PE TTM —
TSR TTM (16.14%)
Mkt cap €201.2M
ROIC (3.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€3.43
29.53%
(74.59%)
Hold 3|2|11|3|1
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.02
0.02
0.02
0.03
(8.33%)
0.73%
16.08%
24.67%
Revenue€M
9.529
9.723
9.499
10.00
10.17%
8.36%
7.60%
7.24%
Peers (US$225.9M)
Cap (US$)
PE
1.273B
16.58x
115.7M
25.56x
Capital
TTM
5Y
10Y
Leveragex
0.853
0.081
0.075
EBIT/Intx
0.923
0.135
0.135
Own earn%
349.22
(3.79)
(4.79)
Sh yield%
40.74
42.37
42.34
Owners
Insiders/Inst%
14.51
60.82
Short interest%
0.74
SBC / revenue%
3.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
10–14
$1 testx
—
Incr. ROIC%
3